Detalhe da pesquisa
1.
Osteocytes and Paget's Disease of Bone.
Curr Osteoporos Rep
; 22(2): 266-272, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38457001
2.
Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.
J Cell Biochem
; 122(3-4): 335-348, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33107091
3.
Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment.
Blood
; 119(8): 1888-96, 2012 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-22223826
4.
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis.
Res Sq
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38558984
5.
Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation.
JCI Insight
; 8(14)2023 07 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37338990
6.
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Cell Rep Med
; 4(7): 101110, 2023 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37467717
7.
Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction.
Neoplasia
; 28: 100785, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35390742
8.
Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.
Blood
; 113(20): 4894-902, 2009 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-19282458
9.
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.
Cancer Res
; 81(19): 5102-5114, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34348968
10.
A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hum Mol Genet
; 17(23): 3708-19, 2008 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18765443
11.
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
J Clin Invest
; 117(1): 133-42, 2007 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17187080
12.
Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.
JCI Insight
; 5(6)2020 03 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32078587
13.
Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts.
Oncotarget
; 10(28): 2709-2721, 2019 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31105871
14.
1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
J Steroid Biochem Mol Biol
; 110(3-5): 269-77, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18501591
15.
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.
J Hematol Oncol
; 11(1): 123, 2018 10 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30286780
16.
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.
Bone
; 40(2): 316-22, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16996813
17.
Experimental models of Paget's disease.
J Bone Miner Res
; 21 Suppl 2: P55-7, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17229020
18.
Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
J Bone Miner Res
; 21(3): 446-55, 2006 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-16491293
19.
Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
J Bone Miner Res
; 21(10): 1657-65, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16995821
20.
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression.
Ann N Y Acad Sci
; 1068: 240-3, 2006 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-16831924